CPMV
Price
$0.49
Change
+$0.13 (+36.11%)
Updated
Jun 27 closing price
Capitalization
3.57M
RANI
Price
$0.53
Change
+$0.02 (+3.92%)
Updated
Jul 2, 04:57 PM (EDT)
Capitalization
17.85M
36 days until earnings call
Interact to see
Advertisement

CPMV vs RANI

Header iconCPMV vs RANI Comparison
Open Charts CPMV vs RANIBanner chart's image
Mosaic ImmunoEngineering
Price$0.49
Change+$0.13 (+36.11%)
Volume$200
Capitalization3.57M
Rani Therapeutics Holdings
Price$0.53
Change+$0.02 (+3.92%)
Volume$7.7K
Capitalization17.85M
CPMV vs RANI Comparison Chart in %
Loading...
CPMV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPMV vs. RANI commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPMV is a Hold and RANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (CPMV: $0.49 vs. RANI: $0.53)
Brand notoriety: CPMV and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPMV: 16% vs. RANI: 24%
Market capitalization -- CPMV: $3.57M vs. RANI: $17.85M
CPMV [@Biotechnology] is valued at $3.57M. RANI’s [@Biotechnology] market capitalization is $17.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPMV’s FA Score shows that 0 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • CPMV’s FA Score: 0 green, 5 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, CPMV is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPMV’s TA Score shows that 3 TA indicator(s) are bullish while RANI’s TA Score has 3 bullish TA indicator(s).

  • CPMV’s TA Score: 3 bullish, 3 bearish.
  • RANI’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both CPMV and RANI are a good buy in the short-term.

Price Growth

CPMV (@Biotechnology) experienced а +37.08% price change this week, while RANI (@Biotechnology) price change was +5.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

CPMV is expected to report earnings on Apr 15, 2025.

RANI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($17.9M) has a higher market cap than CPMV($3.57M). CPMV YTD gains are higher at: -29.621 vs. RANI (-62.518). CPMV has higher annual earnings (EBITDA): -729.66K vs. RANI (-48.83M). RANI has more cash in the bank: 15.9M vs. CPMV (85.9K). CPMV has less debt than RANI: CPMV (1.61M) vs RANI (25.7M). RANI has higher revenues than CPMV: RANI (1.2M) vs CPMV (0).
CPMVRANICPMV / RANI
Capitalization3.57M17.9M20%
EBITDA-729.66K-48.83M1%
Gain YTD-29.621-62.51847%
P/E RatioN/AN/A-
Revenue01.2M-
Total Cash85.9K15.9M1%
Total Debt1.61M25.7M6%
FUNDAMENTALS RATINGS
CPMV: Fundamental Ratings
CPMV
OUTLOOK RATING
1..100
39
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPMVRANI
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CPMV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASAN13.670.17
+1.26%
Asana
BR244.731.70
+0.70%
Broadridge Financial Solutions
CLB11.52N/A
N/A
Core Laboratories
LEXX0.85-0.02
-2.30%
Lexaria Bioscience Corp
SCWO0.22-0.10
-30.62%
374Water

CPMV and

Correlation & Price change

A.I.dvisor tells us that CPMV and RANI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPMV and RANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPMV
1D Price
Change %
CPMV100%
N/A
RANI - CPMV
23%
Poorly correlated
+3.56%
AKESF - CPMV
22%
Poorly correlated
N/A
PPTDF - CPMV
21%
Poorly correlated
N/A
SIGY - CPMV
6%
Poorly correlated
N/A
HLOSF - CPMV
5%
Poorly correlated
N/A
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-0.08%
XENE - RANI
35%
Loosely correlated
N/A
ADVM - RANI
32%
Poorly correlated
+6.05%
DRUG - RANI
31%
Poorly correlated
+1.80%
UBX - RANI
31%
Poorly correlated
-10.67%
VNDA - RANI
30%
Poorly correlated
-0.85%
More